Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update

NEXT STORY
Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021 Virtual Meeting
PREV STORY
G1 Therapeutics Initiates Randomized Double Blind Placebo Controlled Phase 2 Study of COSELA™ (trilaciclib) in Non-Small Cell Lung Cancer (PRESERVE 4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Delcath Announces Health Authority Approval for CHEMOSAT in Brazil

Discussions Underway With Potential Commercialization PartnersNEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Delcath ...

author_avatar
NASDAQ Market News

Inovio’s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation

PLYMOUTH MEETING, Pa., July 06, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

author_avatar
NASDAQ Market News

Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial Results and Corporate Highlights

-Presented Updated Clinical Data from Ongoing Phase 1 Trial of DCC-2618 at ESMO-  -Completion ...

author_avatar
NASDAQ Market News